Tomaszewski (2009)[32]
|
In vitro |
Pubocervical fascia (PCF) obtained from a 56 yr old woman with SUI and POP |
Same as intervention group but without mesh exposure |
Collagen type I (Col I) biosynthesis was assessed after 48, 96, and 144 hrs |
Biosynthesis of aminoterminal propeptide of type I procollagen as a marker of Col I biosynthesis in cultured PCF fibroblasts |
Fibroblasts from PCF taken from a menopausal woman with SUI and POP are capable of Col I biosynthesis after estrogen and phytoestrogen treatment. |
Abstract in English |
|
PCF fibroblasts cultured with mono- or multifilament mesh and exposed to 17β-estradiol (E2), estriol or phytoestrogen daidzein |
|
|
|
There was decreased fibroblast biosynthesis of aminoterminal propeptide of type I procollagen in the study subgroup using multifilament polypropylene mesh. The most significant difference between assessed groups was recorded within the 96th and 144th hour. It is possible that decrease of collagen type I biosynthesis after 144 hours of the experiment was caused by aging of the culture (no p-value). |
Full text in Polish |
|
|
|
|
|
|
|
|
|
|
|
|
Summary: Col I levels in cultured PCF fibroblasts taken from a 56 yo menopausal woman with SUI and POP increased after exposure to estrogen and daidzein. |
|
Tomaszewski (2010)[33]
|
In vitro |
Pubocervical fascia (PCF) obtained from a 56 yo woman with SUI and POP |
Skin fibroblasts |
Cultures were run for 216 hrs and the media were replaced every 72 hrs |
Procollagen type 1 N-terminal propeptide (PINP) as a marker of Col I synthesis by PCF fibroblasts cultured with mono- or multifilament polypropylene mesh in the presence of estrogens and a phytoestrogen |
Fibroblasts exposed to estriol or daidzein produced more Col I than those treated with estradiol regardless of the mesh applied. |
Abstract in English |
|
PCF fibroblasts cultured with mono- or multifilament mesh and exposed to 17β-estradiol (E2), estriol or phytoestrogen daidzein |
|
|
|
In the presence of monofilament mesh, peak PINP concentration increased persistently with estriol and daidzein throughout the study whereas the peak PINP was between 72-144 hrs for estradiol. |
Full text in Polish |
|
|
|
|
|
In the presence of multifilament mesh, the rate of Col I production dropped after 144 hrs in all cultures. |
|
|
|
|
|
|
No data available in abstract. |
|
|
|
|
|
|
Summary: PCF fibroblasts produced more Col I when exposed to estriol or daidzen regardless of the type of vaginal prolapse mesh applied. |
|
Tomaszewski (2010)[34]
|
In vitro |
Pubocervical fascia (PCF) obtained from a 52 yo premenopausal woman undergoing SUI surgery |
PCFs without treatment |
Cultures were run for 216 hrs and the media were replaced every 72 hrs |
N-terminal propeptide of type III procollagen (PIIINP) as a marker of collagen type III (Col III) synthesis by PCF fibroblasts cultured with mono- or multifilament polypropylene mesh in the presence of estrogens, a phytoestrogen, and an anti-estrogen |
High collagen type III synthesis persisted throughout the study period only in cultures containing monofilament mesh stimulated with estriol. The highest total PIIINP production was observed in culture treated with tamoxifen regardless of mesh types. |
Abstract in English |
|
|
|
|
|
No data available in abstract |
Full text in Polish |
|
PCF fibroblasts cultured with mono- or multifilament mesh and exposed to 17β-estradiol (E2), estriol, phytoestrogen daidzein, or tamoxifen |
|
|
|
Summary: Col III only showed a persistent increased production by PCF fibroblasts in cultures containing monofilament mesh stimulated with estriol. The highest total Col III production was observed in culture treated with tamoxifen regardless of the type of mesh. |
|
Iwanaga (2016)[35]
|
In vitro and animal, mice |
For human subjects: Oxytocin receptor (OXTR) mRNA expression in human USL collected from 11 premenopausal women with normal pelvic support (controls, CTL) vs. 6 premenopausal women with POP vs. 7 postmenopausal women with POP. |
Up to 70 week old mice |
For human subjects: Oxytocin receptor (OXTR) mRNA expression in human USL |
For human subjects: OXTR expression was decreased by 65% in the premenopausal POP group and by 78% in the postmenopausal POP group (both p<0.05) compared to premenopausal CTL. |
Abstract only |
|
For mice; OXTR expression was compared between
mice with prolapse and age-matched mice without prolapse (n=3 and 10, respectively)
Ovx mice for 2 months (nulliparous or NP, n=6, multiparous or MP, n=6)
Ovx mice for 2 months further treated with and without 2-day estradiol treatment (n=5 and 6, respectively)
12 months mice undergoing sham surgery and treated with vs. without 2-day estradiol treatment (n=5 and 6, respectively)
70 weeks old NP mice raised on a phytoestrogen diet (n=10) vs. phytoestrogen-free diet (n=10)
|
|
For mice: OXTR expression was compared in mice USL
-
i)
with vs. without prolapse
-
ii)
Ovx in NP and MP mice vs. sham surgery
-
iii & iv)
with vs. without E2 treatment to sham and OVX mice
-
v)
phytoestrogen diet vs. phytoestrogen-free diet
|
For mice:
OXTR was decreased by 90% in mouse USL with POP compared to CTL (p<0.05).
OVX resulted in significantly decreased OXTR expression in NP and MP mice compared to sham (p<0.05)*.
Treatment with E2 to a MP sham and OVX mice increases expression of OXTR (p<0.05)*.
Phytoestrogen diet had a significant impact on OXTR expression in USL compared to phytoestrogen free diet (p<0.05)*.
|
|
|
|
|
|
*no specific data available in abstract. |
|
|
|
|
|
Summary: Both estradiol and a phytoestrogen diet increased expression of OXTRs and had a significant impact on OXTR expression in the USL. |
|
Jiang (2017)[36]
|
Prospective cohort of women having transvaginal surgery for POP and/or SUI |
Puerarin 0.429 mg/day for 30 days, n=30 |
Placebo for 30 days, n=22 |
June 2010 to Nov 2012 |
POP symptoms: non-validated score based on POP-Q exam (positive or strongly positive improvement in symptoms if 1+ or 2+ stage improvement, respectively) |
Patients treated with puerarin had significant improvement of POP vs. control patients (positive: 57 % vs. 0%, and strongly positive 35% vs. 0%, p<0.05). Elastin positive rate (9.8% ± 2.8% vs 2.8% ± 1.3%, p<0.05), collagen I/III ratio (1.1 ± 0.3 vs 0.5 ± 0.3, p<0.05), NPY, VIP and TGF-β was significantly increased in the puerarin group compared to control (all p<0.05). |
Full text |
|
|
|
|
Vaginal tissue: biopsies of participants’ prolapsed tissue obtained. |
|
|
|
|
|
|
Expression of elastin, collagen, neuropeptide Y (NPY), vasoactive intestinal polypeptide (VIP) and transforming growth factor beta (TGF-β) was evaluated in all patients using immunohistochemistry |
Summary: After 30 days, women treated with puerarin had significant improvement of POP. The expression of elastin positive rate and collagen I/III ratio were significantly increased in the puerarin group. NPY, VIP, and TGF-β levels were also significantly increased. |